YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

J&J COVID-19 vaccine adds $502M to Q3 sales

Posted online

Johnson & Johnson's COVID-19 vaccine added $502 million to its third-quarter revenue.

Revenue during the quarter was $23.3 billion, short of the $23.7 billion expected by analysts.

Adjusted earnings per share came to $2.60, beating the $2.35 per share estimate.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences